Skip to main content
Top
Published in: Intensive Care Medicine 7/2001

01-07-2001 | Original

A multicenter, open-label, prospective, randomized, dose-ranging pharmacokinetic study of the anti-TNF-α antibody afelimomab in patients with sepsis syndrome

Authors: James Gallagher, Charles Fisher, Bruce Sherman, Mark Munger, Bruce Meyers, Travis Ellison, Steven Fischkoff, William T. Barchuk, Leah Teoh, Raja Velagapudi

Published in: Intensive Care Medicine | Issue 7/2001

Login to get access
Metadata
Title
A multicenter, open-label, prospective, randomized, dose-ranging pharmacokinetic study of the anti-TNF-α antibody afelimomab in patients with sepsis syndrome
Authors
James Gallagher
Charles Fisher
Bruce Sherman
Mark Munger
Bruce Meyers
Travis Ellison
Steven Fischkoff
William T. Barchuk
Leah Teoh
Raja Velagapudi
Publication date
01-07-2001
Publisher
Springer-Verlag
Published in
Intensive Care Medicine / Issue 7/2001
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI
https://doi.org/10.1007/s001340100973

Other articles of this Issue 7/2001

Intensive Care Medicine 7/2001 Go to the issue